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Interview with Dean Miller
Quill and Scope Staff
r. Donald Douglas Miller is the dean of the School of Med Monsanto brought
icine at New York Medical College. He was named to the
their experience,
post in 2014 after years of experience in medical research, edu
Boeing brought their
cation, and administration. In keeping with the New Frontiers
experience, people
theme of this issue of Quill and Sc(}pe, we sat down with Dr.
from Budweiser,
Miller to find out more about his past, his vision for the School brought the beer. That
was always good.
of Medicine, and what this has to do with Wayne Gretzky. This
interview has been lightly edited and condensed.
You don’t need an
Quill & Scope: Your career has spanned many different
MBA to be a success
realms. How did you transition from clinical practice and
ful small business
research, where it seems like you were in your earlier career,
owner in practice.
to focus more on education and administrative work? What
You can certainly run
got you, or inspired you, to go into medical education?
a practice of a mod
erate size (as many
Dr. Miller: Transition in a career in academic medicine is
of our colleagues do)
often hard to predict. It often is just situational. Sometimes
without any formal
its the person that doesn’t step back when they ask you to
business training. You do have to learn the skills and ac
do something. In my career, I was doing a lot of clinical
quire the management team that eventually can run it for
research and clinical care and working in a limited admin
you, because you have time limits and skill limits that pre
istrative role [in Saint Louis University]. As good bosses
clude that. So the MBA is not a prerequisite to being a good
and mentors do, my boss said, “Why don’t you take on this
physician and small business manager. The modern prac
role and become our key administrator in this hospital and
tice of medicine has changed in the 20 years since I’ve been
make sure that our resident training program there is as
doing administrative work dramatically. 1996 was when I
strong as it can be?” I said, “Sure , I’ll do that.” In the doing
began my administrative role through now. It’s been just
of that, I also suggested that I get support for an MBA
complete transformation of healthcare delivery. You know
that I was going to do at the time, so I did them both at
about what’s going on and many of the drivers of the busi
the same time and developed a gene for greater interest in
ness are changing. But at this point in time, nothing about
administration. A couple of years later, having done that,
what anybody learned in the past has really prepared them
he stepped down as the chair, and the Dean asked me if I
for what’s going to happen in the future. It’s very much a
wanted to be the chair of the department. I thought I was
paradigm shift and a new set of business rewards and risks,
ready and after consulting with some people I trusted, I
so that population health and health management, the new
took that job. That really switched me onto the administra
buzzwords are really just a euphemism for health systems
tive side.
becoming more aggregated without any anti-trust concerns
to prevent it with Obamacare. Secondly, more risk manage
Q&S: Was the MBA [master’s in business administration]
ment is involved in more of a capitated insurance model, so
sort of a way to buttress your administrative roles and get
these health systems are actually becoming HMOs [health
some skills?
maintenance organizations]. The third part of what is going
on, which most physicians have really struggled with, is
DMfYes, I think it was a confidence and skill builder.
data management and large data sets, which your insurer
Mostly on the management side, less on the financial side,
already knows about you.
although I did both. I’ve used a lot of what I’ve learned and
have developed since then as a basis for administrative style
I just had lunch with the dean of Hofstra Medical School.
and strategy.
Northwell [the healthcare system connected to Hofstra] has
developed its own insurance company. Their insured clients
Q&S: Can you speak a little bit about what it’s like to be a
aren't, as he said, sick now, but when you see the other side
physician in the business world, where most people who
of the data that they’re able to look at, and you realize how
get MBAs do not have any science or medical background?
powerful that health insurance data is, it opens up another
DM: I was the only physician in my MBA class. The group
whole complexity to how we will manage care going for
of people I worked with was actually an international
ward. I don’t know what I would advise a medical student
group from all around the world that were doing business
right now, other than to get a good understanding of what
training. I brought my experience to it and the people from
the broad levers are of the healthcare business.

D
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Q&S: I remember at the White Coat Ceremony [Aug.
2015], you spoke a lot about how important it is to be edu
cated and knowledgeable about a lot of these big changes.
But it seems like the traditional medical curriculum, which
we have to follow, and we should follow, has very little on,
if anything, about healthcare systems. It’s a lot of stuff on
basic and clinical sciences, which are very important. How
can students really learn more about these larger issues,
while also trying to pass physiology?
DM: There are certain elements of the curriculum that stan
dard required elements. Then there are some electives and
selectives. I think many students work naturally during the
required elements—you’re pretty much just keeping up with
the work. You’re a student, you get ready to pass the test
based on that work. I think the judicious use of research
time, selective time, and elective time, which currently is
largely directed towards get
ting a better residency, could
be used in a more altruistic
way to get a better view of the
world and of what the future
of medicine will be. I don’t
want to sound cynical—but I think you can certainly get
a leg up by doing an elective or selective in orthopedics if
you want to be an orthopedic surgeon. It’s almost a mantra
that you need to do—you've got to do research. All these
things that we have traditionally adopted and advocated for
are probably still in play. But if you want to get ahead of the
game, that would be a game changer. One suggestion that
Dr. Smith [of Hofstra] had was, why don’t you send one of
your students over to work in our insurance company on
an elective for a week or two? They’ll learn more about how
healthcare works than they could ever learn in any class
and it will be maybe an eye-opener or a career-changer.
Maybe they’ll develop a whole new area of interest. We
need to make more of that available. We need to make it
more relevant to the students that still want to compete
for their residencies, but maybe also want to have a longer
view, sort of like selling short, selling long, you get a couple
of different views to your career.

riskier, but probably are necessary to take the
risk. And so, from experience over the course of
time, building research programs, that we’ve been recently
developing a strategy in, and we vetted it with our strategic
plan, to be more translational. Bench to bedside scientists...
think about not just what goes on in a basic lab, but how
get it applied.
Q&S: And using current researchers at NYMC to reach that
goal?
DM: Yes, trying to reinvent and rejuvenate their career
because, to be fair, and we agree on this—that’s where the
NIH funding is going. It’s leaving the basic sciences, to
their chagrin, though not completely. But the new money^
is going to precision medicine and cancer, and to more
translational programs. So we’re trying to build very trans
lational research programs.
If we can’t do that, then we
probably won’t be as com
petitive. Capabilities plus
partnerships equals compet
itiveness, is our philosophy.
That’s true when you’re building educational programs,
so we talk about the new educational approach with other
medical schools or nationally, trying to bring in those ideas.
Faculty development, student programming in new areas of
concentration, and stuff like that, that we’ve been working
on. This, I think, works someplace else that I’ve heard about
it. People are quite receptive to that approach.

we're trying to build very transla
tional research programs.”

Q&S: You were quoted [in the Chironian] as saying some
thing along the lines of, one of the advantages you have
as coming as having never having been at NYMC before
is that you bring a fresh perspective. 1 think talking about
people’s education and population health can be one of
them. Are there other things you’re trying to implement
or work on now that come from this place of bringing in a
fresh pair of eyes to your position?
DM: Yes, I hope so. I try not to be, you know, "Mr. Knowit-all." The experience I’ve had in other systems of care, in
other health systems, and in other parts of the country, I
hope, has informed what I think works generally, and what
might be uniquely helpful here. If you spend long enough
in a sector, you develop a certain playbook of things that
generally speaking, work. Other things might be a little
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Q&S: That’s good that they’re receptive, because you might
imagine at an old institution like NYMC, there might be
some resistance to the new guy coming in and with all
these fresh ideas.
DM: Yes, I think you've got to "build a village" around all
these issues. There are a lot of people with very good ideas
and that have done very good work. What I always try to
do is take time to listen and understand what the platform
is, talk about it with the stakeholders and the advocates
for that approach and see if there’s something we can graft
onto. That's an enhancement that doesn’t require complete
disruptive change.
Q&S: I think this sort of relates to a role, that I don’t think
most students know that you have, is that you’re the chief
scientific officer at BioInc, which is something that we have
on campus, but I don’t think most students interact with. I
was wondering if you could ^eak about your role, and what
is BioInc, and if it really should matter to students at all.
DM: “BioInc at New York Medical College” is descriptive of
our bioincubator, which is a new company startup envi
ronment. It’s in the BioInc facilities on Dana Road, where
the simulation and clinical skills are; on the other side of
the building there are seven companies. [It hosts] Philips
Healthcare, big companies, small companies, that are doing
a combination of biotechnology and high-technology
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research towards new products. That’s commercialization you’re creating jobs, you’re creating new products. In recent
weeks, we hosted an event we called the “Pitch Contest.”
Angel investors came and decided whether they wanted to
put money into these ideas, to fund them, to the level of
being commercially viable products. The idea is to foster
opportunity for both university scientists and investiga
tors, outside clients, and strategic partnerships with big
companies. This allows us to help the Philips Healthcare
research group that was going to^otherwise be moved to
Massachusetts to be retained in New York. Eleven extreme
ly well-trained colleagues and scientists, instead of having
to move to Cambridge, Massachusetts, were able to stay in
New York and work with our NYMC colleagues on their
projects. My role is just to help to make sure the science is
as robust as it can be and that we don’t miss opportunities
to grow in different sectors. We’re in new drugs, biosensors,
high-technology, computational genomics, we’re kind of
taldng advantage of our available options. We like to imag
ine that we’re the fastest growing, soon-to-be best, incuba
tor between Downtown Manhattan and Kendall Square,
Cambridge. That’s the big goal.
Q&S: That would really be something. How do you think
this should relate to students?
DM: Just like students might like to embed into a health
insurance company to kind
of learn how that part of the
...
world might work going for
ward, we have opportunities
to place students in compa
nies at Bioinc and give them
some experience as to what
it’s like to start up a compa
ny, to talk with these owners
of these companies. Some of them might be faculty-oper
ated, some of them will be corporately-operated, but we’d
like to imagine that students who want to be innovative and
might have ideas that they would want to commercialize.
Students I’ve worked with in the past have developed apps
for education purposes, and we can help to create intel
lectual property and protect that for students if they want.
We-hope students that have research ideas that come out of
their projects and they actually develop companies—I’ve
always been amazed at how they have time to actually do
that, but it’s kind of like working on your 64-Mustang in
the garage and you just make time on the weekends.

happy. It was all continuous three-year curriculum, there
were no breaks. They were slightly more mature students.
They wanted an accelerated program and were willing to
put up with the limited quality of life that goes on with
three years of continuous work. They wanted to get it done.
I think there is value to the fourth year if the fourth year
is part of a well-thought out curriculum that gives all sorts
of opportunities for enrichment in the four years. If you
look at the curriculum and said, “Really we could teach this
curriculum in three years,” get people an MD degree, and
get them into the workforce or their residency programs
earlier, it would be nice to offer that to people. But it’s very
hard to do that as a track. You’ve got to really commit one
way or the other. It would have to work for everybody. I
would say, knowing the students and talking the students, I
think as students, you generally value the work-life balance
that allows you to move through the work. And sure, you
can do it quicker, but you wouldn’t have the relationship
development time, you wouldn’t have the breaks, you
wouldn’t see your families as much.
Q&S: Such as taking advantage of opportunities like BioInc...
DM: Yes, exactly. The enrichment opportunities would be
limited by that. You can master the curriculum and go
through it—I think there are very bright students who can
handle the work in three
years--but it would probably
change the whole experience.
The average student that
I’ve met with really values
those extra things. It’s my
feeling that most medical
schools stay with a four year
MD program because they
also believe that that’s in the best interests of the students’
well-being, maturation as individuals, as well as their ability
to have work-life balance.

[NYMC has] the fastest grow
ing, soon-to-be best, incubator be
tween Downtown Manhattan and
Kendall Square, Cambridge.”

Q&S: Three-year medical programs are getting a lot more
attention. Can you talk more about whether the college
here would develop one?
DM: We’ve talked about it hypothetically. One of the other
schools in Alberta, in Calgary, was a three-year medical
school. We could compare ourselves to them in many ways
in quite a detailed manner. Their students completed the
three-year curriculum, were well-trained and seemed to be

So probably we won’t do that. We’d like to create more
value-added opportunities. We have committed to the idea
that our medical school will have a more progressive cur
riculum. In the last ten years, that’s meant more integration,
earlier clinical experience. I’m not convinced of the value of
[early clinical exposure] even though it’s a widely adopted
concept that we integrate more clinical work in the early
years.
Q&S: From my perspective as a student, there seems to
be some tension from the LCME visit, where there were a
lot of things that we had to change to be reaccredited. On
the other hand, there are a lot of things that we would like
to do independently because we think they’re good ideas.
How do you balance those things? Now that the LCME visit
is over, what are some things that are still being worked on?
DM: First of all, we want to be well-accredited by the
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LCME. The LCME does require curriculum management
and curriculum enhancement. Eor example, one of their
premises is less big classroom didactic, and more smallgroup interactive. We’ve tried to produce a relatively heavy
classroom content of the past into a kind of 50/50 prop
osition. We’re not quite there yet. We’re working in that
direction. I think that’s a good trend.
The other big trend is more clinical experience early,
because generally speaking, students feel connected to
why they’re working so hard on the core work in the basic
sciences if they can sort of see some clinical relevance. So
we do that with patients and/or simulation in clinical skills,
so that’s been another trend that I think we’re a part of.
We’ve caught up, if you will, to those two trends by having
our own more integrated curriculum and our own better
clinical skills and simulation capability.
Having done that, then what do you do to really make the
curriculum more valuable? The new idea, which is extra
curricular, is areas of concentration, where every student
will have the opportunity to pursue an area of interest
or passion for them, whether it’s in biomedical ethics or
healthcare safety or biomedical research or other areas that
will be developed. So when you leave, you’ll have commit
ted to completing the curriculum and it will continue to
evolve in a related area. You’ll also have this sense that you
developed a higher understanding of an area that themat
ically will always be part of your career. You could argue
that if you did biomedical ethics, you’re always going to be
thinking about that in a way that’s probably a little bit better
informed by what you’ve learned than maybe your aver
age doctor. That is how we’ll drive the curriculum going
forward.

model is to embed in a hospital on a clerkship
rotation. You do the surgical clerkship and in the
old days, when I was in medical school, patients stayed in
the hospital for a week, two weeks, around surgery. Now
they’re in and out. The entire surgery experience involves a
tremendous amount of pre-work. Patients drop in, may
be for a day surgery or a two-day admission, and then go
home for post-op care right out of the hospital. If we’re just
dropping people into a rotation that says, “Hi Mr. Smith,
your operation is in three hours. Did you eat anything
after midnight?” And then they have their procedure and
they’re leaving by eight o’clock that night—that’s not what
surgery’s all about anymore. We have to explore and look
at those current dogmas of medical education that reflect
the clerkship experience. I’d like to see us put more students
into multidisciplinary clinic settings. I’d like to see students
embedded into large practice groups. I’ve visited with the
Caremount Medical Group, which has multiple primary
and specialty care capabilities. I think they would be won
derful partners for a longitudinal integrated clerkshisp.
Q&S: So essentially, you want students to be integrated in
settings where healthcare as a whole is moving.
DM: Yes, you’re right, exactly. We want to make sure that
what we do in medical education is relevant to where
healthcare is going.
Q&S: And not necessarily just the way it was done in past
years.
DM: Yes, that’s what we’re trying to be. That would be in a
nutshell, as you said, where we’re trying to be. We’re trying
to - I'll paraphrase the Gretzky saying - we’re trying to skate
to where the puck is going, not to where it isn’t.

I think we will also look at novel approaches to expose our
students to clinical clerkships. The traditional clerkship
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